BIO-TECHNE Corp

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company's products support scientific investigations into biological processes and molecular diagnostics, aiding in drug discovery and providing tools for clinical tests and diagnoses. Bio-Techne manages its business through two operating segments: Protein Sciences and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures high-quality biological reagents used in life science research, diagnostics, and cell and gene therapy. This segment also offers proteomic analytical tools, both manual and automated, for protein analysis, automated western blot, and multiplexed ELISA workflows. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market. It also provides exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications. Bio-Techne, a Minnesota corporation founded in 1976 as Research and Diagnostic Systems, Inc., became publicly traded in 1985. Its common stock is listed on the NASDAQ under the symbol "TECH." The company operates globally with offices in North America, Europe, and Asia. It manufactures hundreds of thousands of diverse products in multiple locations in North America, the U.K., Canada, Switzerland, and China.